ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 106 filers reported holding ACCELERATE DIAGNOSTICS INC in Q1 2022. The put-call ratio across all filers is 12.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2 | 0.0% | 3,081 | 0.0% | 0.00% | – |
| Q1 2023 | $2 | 0.0% | 3,081 | 0.0% | 0.00% | – |
| Q4 2022 | $2 | -100.0% | 3,081 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | +66.7% | 3,081 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 3,081 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | -76.5% | 3,081 | -6.1% | 0.00% | – |
| Q4 2021 | $17,000 | +750.0% | 3,281 | +1540.5% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,067,560 | $53,364,000 | 28.19% |
| Selkirk Management LLC | 208,000 | $5,368,000 | 2.94% |
| Iguana Healthcare Management, LLC | 270,000 | $6,969,000 | 2.20% |
| Opaleye Management Inc. | 100,600 | $2,596,000 | 1.03% |
| Miura Global Management | 600,000 | $15,486,000 | 0.94% |
| DSC Advisors, L.P. | 57,400 | $1,481,000 | 0.77% |
| Cannell & Co. | 1,016,828 | $26,244,000 | 0.74% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 276,549 | $7,138,000 | 0.61% |
| Harvest Capital Strategies LLC | 100,000 | $2,581,000 | 0.33% |
| Raging Capital Management, LLC | 93,932 | $2,424,000 | 0.31% |